Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X0002 Spray in Osteoarthritis of the Lumbar Spine
NCT03110523Phase 3Withdrawn
- Sponsor
- Techfields Pharma
- Start
- Mar 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ibuprofenamine hydrochloride in Osteoarthritis of the Lumbar Spine (OA-LS), low back pain (LBP), sponsored by Techfields Pharma. Planned start Mar 2023; status: withdrawn.
02
Drugs
ibuprofenamine hydrochloride
03
Conditions
Osteoarthritis of the Lumbar Spine (OA-LS)low back pain (LBP)
Beyond the preview
Go deeper on NCT03110523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110523.